Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib
| Image |  |
|---|---|
| Description | scientific article published on June 2011 |
| Author/s |
author: Mark G Kris Camelia S Sima William Pao |
| Publication date | June 1, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |